039691597	039691597	CD	B-NP	O
|	|	NN	I-NP	O
AGH	AGH	NN	I-NP	O
|	|	NN	I-NP	O
16685394	16685394	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
9740407	9740407	CD	B-NP	O
|	|	CC	I-NP	O
10/24/2005	10/24/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
NON	NON	NNP	I-NP	I-protein
ST	ST	NNP	I-NP	I-protein
ELEVATION	ELEVATION	NNP	I-NP	I-protein
MYOCARDIAL	MYOCARDIAL	NNP	I-NP	I-protein
INFARTION	INFARTION	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/6/2005	7/6/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/24/2005	5/24/2005	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
KONEVAL	KONEVAL	NNP	B-NP	O
,	,	,	O	O
MAURICIO	MAURICIO	NNP	B-NP	O
M.D.	M.D.	NNP	I-NP	O
PRIMARY	PRIMARY	NNP	I-NP	O
CARE	CARE	NNP	I-NP	O
PHYSICIAN	PHYSICIAN	NNP	I-NP	O
:	:	:	O	O
Kelley	Kelley	NNP	B-NP	O
Vanvolkenburg	Vanvolkenburg	NNP	I-NP	O
,	,	,	O	O
MD	MD	NNP	B-NP	O
This	This	NNP	I-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
interim	interim	JJ	I-NP	O
discharge	discharge	NN	I-NP	O
summary	summary	NN	I-NP	O
dictation	dictation	NN	I-NP	O
and	and	CC	O	O
there	there	EX	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
an	an	DT	B-NP	O
addendum	addendum	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
will	will	MD	B-VP	O
include	include	VB	I-VP	O
the	the	DT	B-NP	O
discharge	discharge	NN	I-NP	O
medications	medication	NNS	I-NP	O
and	and	CC	O	O
follow-up	follow-up	JJ	B-NP	O
appointments	appointment	NNS	I-NP	O
.	.	.	O	O

ADMITTING	ADMITTING	VBG	B-VP	O
DIAGNOSIS	DIAGNOSIS	NN	B-NP	O
:	:	:	O	O
Non-ST	Non-ST	JJ	B-NP	O
elevation	elevation	NN	I-NP	O
MI	MI	NN	I-NP	O
.	.	.	O	O

PRINCIPAL	PRINCIPAL	JJ	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Non-ST	Non-ST	JJ	B-NP	O
elevation	elevation	NN	I-NP	O
MI	MI	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
PCI	PCI	NN	I-NP	O
with	with	IN	B-PP	O
drug	drug	NN	B-NP	O
eluding	elude	VBG	B-VP	O
stent	stent	JJ	B-NP	O
x3	x3	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
SVG	SVG	NN	I-NP	O
to	to	TO	B-PP	O
RT	RT	NN	B-NP	B-protein
PDA	PDA	NN	I-NP	I-protein
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Acute	Acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Anemia	Anemia	NNP	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Insulin	Insulin	NN	B-NP	B-protein
dependent	dependent	JJ	I-NP	O
diabetes	diabete	NNS	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Hyponatremia	Hyponatremia	NN	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
61-year-old	61-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
significant	significant	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
inferior	inferior	JJ	I-NP	O
MI	MI	NN	I-NP	O
in	in	IN	B-PP	O
1988	1988	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
status	status	NN	B-NP	B-protein
post	post	NN	I-NP	I-protein
CABG	CABG	NN	I-NP	I-protein
,	,	,	O	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
non-ST	non-ST	JJ	I-NP	O
elevation	elevation	NN	I-NP	O
MI	MI	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
significant	significant	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	O
risk	risk	NN	I-NP	O
factors	factor	NNS	I-NP	O
including	include	VBG	B-PP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
hyperlipidemia	hyperlipidemia	NN	B-NP	O
,	,	,	O	O
smoking	smoking	NN	B-NP	O
,	,	,	O	O
age	age	NN	B-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
50	50	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
diabetes	diabete	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
vasculopathies	vasculopathy	NNS	I-NP	O
with	with	IN	B-PP	O
interventions	intervention	NNS	B-NP	O
on	on	IN	B-PP	O
bilateral	bilateral	JJ	B-NP	O
carotids	carotid	NNS	I-NP	O
,	,	,	O	O
CABG	CABG	NN	B-NP	B-protein
,	,	,	O	O
aortofemoral	aortofemoral	JJ	B-NP	O
bypass	bypass	NN	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
CVA	CVA	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
likely	likely	JJ	B-NP	O
renal	renal	JJ	I-NP	O
artery	artery	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
two-week	two-week	JJ	I-NP	O
history	history	NN	I-NP	O
crescendo	crescendo	NN	I-NP	O
angina	angina	NN	I-NP	O
present	present	JJ	B-ADJP	O
at	at	IN	B-PP	O
both	both	CC	O	O
resting	rest	VBG	B-NP	O
and	and	CC	I-NP	O
exertion	exertion	NN	I-NP	O
and	and	CC	O	O
which	which	WDT	B-NP	O
occurred	occur	VBD	B-VP	O
two	two	CD	B-NP	O
times	time	NNS	I-NP	O
per	per	IN	B-PP	O
week	week	NN	B-NP	O
and	and	CC	O	O
resolved	resolve	VBD	B-VP	O
each	each	DT	B-NP	O
time	time	NN	I-NP	O
spontaneously	spontaneously	RB	B-ADVP	O
without	without	IN	B-PP	O
the	the	DT	B-NP	O
requirement	requirement	NN	I-NP	O
of	of	IN	B-PP	O
nitroglycerine	nitroglycerine	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
awoke	awoke	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
sharp	sharp	JJ	I-NP	O
left	left	JJ	I-NP	O
precordial	precordial	JJ	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
progressed	progress	VBD	B-VP	O
to	to	TO	B-PP	O
substernal	substernal	JJ	B-NP	O
chest	chest	NN	I-NP	O
pressure	pressure	NN	I-NP	O
radiating	radiate	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
neck	neck	NN	I-NP	O
down	down	RP	B-PRT	O
her	her	PRP$	B-NP	O
right	right	JJ	I-NP	O
arm	arm	NN	I-NP	O
and	and	CC	O	O
left	leave	VBD	B-VP	O
arm	arm	NN	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
feeling	feeling	NN	I-NP	O
of	of	IN	B-PP	O
left	left	JJ	B-NP	O
arm	arm	NN	I-NP	O
numbness	numbness	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
experience	experience	NN	B-NP	O
significant	significant	JJ	I-NP	O
nausea	nausea	NN	I-NP	O
and	and	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
and	and	CC	O	O
took	take	VBD	B-VP	O
multiple	multiple	JJ	B-NP	O
nitroglycerins	nitroglycerin	NNS	I-NP	O
without	without	IN	B-PP	O
relief	relief	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
Daley	Daley	NNP	B-NP	O
Oer	Oer	NNP	I-NP	O
's	's	POS	B-NP	O
Memorial	Memorial	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Emergency	Emergency	NNP	I-NP	O
Room	Room	NNP	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
ST	ST	JJ	B-NP	O
depressions	depression	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
inferolateral	inferolateral	JJ	I-NP	O
leads	lead	VBZ	B-VP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
T-wave	T-wave	JJ	B-NP	O
inversions	inversion	NNS	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
lateral	lateral	JJ	I-NP	O
leads	lead	NNS	I-NP	O
.	.	.	O	O

Troponin	Troponin	NN	B-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
was	be	VBD	B-VP	O
14	14	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
non-ST	non-ST	JJ	B-NP	O
elevation	elevation	NN	I-NP	O
MI	MI	NN	I-NP	O
management	management	NN	I-NP	O
and	and	CC	O	O
probable	probable	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Notable	Notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
IMI	IMI	NN	I-NP	O
in	in	IN	B-PP	O
1988	1988	CD	B-NP	O
,	,	,	O	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
TPA	TPA	NN	B-NP	O
,	,	,	O	O
CABG	CABG	NN	B-NP	B-protein
in	in	IN	B-PP	O
1999	1999	CD	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Insulin	Insulin	NN	B-NP	B-protein
dependent	dependent	JJ	I-NP	O
diabetes	diabetes	NN	I-NP	O
times	time	NNS	I-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
20	20	CD	B-NP	O
years	year	NNS	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Carotid	Carotid	JJ	B-NP	O
stenosis	stenosis	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
bilateral	bilateral	JJ	I-NP	O
carotid	carotid	NN	I-NP	O
endarterectomies	endarterectomy	NNS	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Hyperlipidemia	Hyperlipidemia	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	VBD	B-VP	O
aortobifemoral	aortobifemoral	JJ	B-NP	O
bypass	bypass	NN	I-NP	O
in	in	IN	B-PP	O
1999	1999	CD	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	VBD	B-VP	O
cerebellar	cerebellar	JJ	B-NP	O
CVA	CVA	NN	I-NP	O
in	in	IN	B-PP	O
2004	2004	CD	B-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
baseline	baseline	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
to	to	TO	B-PP	O
2.5	2.5	CD	B-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Diastolic	Diastolic	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Depression	Depression	NN	B-NP	O
.	.	.	O	O

CURRENT	CURRENT	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Plavix	Plavix	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Lisinopril	Lisinopril	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Toprol-XL	Toprol-XL	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Hydralazine	Hydralazine	NN	B-NP	B-protein
25	25	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
t.i.d.	t.i.d.	NN	I-NP	I-protein
7	7	CD	I-NP	I-protein
.	.	.	O	O

Glyburide	Glyburide	NN	B-NP	B-protein
10	10	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
b.i.d.	b.i.d.	NN	I-NP	I-protein
8	8	CD	I-NP	I-protein
.	.	.	O	O

Lantus	Lantus	NNP	B-NP	O
18	18	CD	I-NP	O
units	unit	NNS	I-NP	O
q.h.s.	q.h.s.	NN	B-NP	O
9	9	CD	I-NP	O
.	.	.	O	O

Isordil	Isordil	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

Nitroglycerin	Nitroglycerin	NN	B-NP	O
sublingual	sublingual	JJ	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
for	for	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Angiotensin	Angiotensin	NN	B-NP	O
receptor	receptor	NN	I-NP	O
blockers	blocker	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
cause	cause	VBP	B-VP	O
hives	hive	NNS	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Adhesive	Adhesive	JJ	B-NP	O
tape	tape	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
cause	cause	VBP	B-VP	O
pleuritis	pleuritis	NN	B-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
retired	retired	JJ	I-NP	O
beautician	beautician	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
45-year	45-year	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
prior	prior	JJ	B-NP	O
smoking	smoking	NN	I-NP	O
and	and	CC	O	O
currently	currently	RB	B-VP	O
continues	continue	VBZ	I-VP	O
to	to	TO	I-VP	O
smoke	smoke	VB	I-VP	O
occasionally	occasionally	RB	B-ADVP	O
.	.	.	O	O

At	At	IN	B-PP	O
a	a	DT	B-NP	O
high	high	JJ	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
smoked	smoke	VBD	B-VP	O
three	three	CD	B-NP	O
packs	pack	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
.	.	.	O	O

Denies	Deny	NNS	B-NP	O
alcohol	alcohol	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
recreational	recreational	JJ	I-NP	O
drug	drug	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
currently	currently	RB	B-ADVP	O
lives	live	VBZ	B-VP	O
alone	alone	RB	B-ADVP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
mother	mother	NN	B-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
died	die	VBD	B-VP	O
at	at	IN	B-PP	O
age	age	NN	B-NP	O
61	61	CD	I-NP	O
of	of	IN	B-PP	O
pyelonephritis	pyelonephritis	NN	B-NP	O
and	and	CC	O	O
myocardial	myocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
.	.	.	O	O

Father	Father	NNP	B-NP	O
died	die	VBD	B-VP	O
at	at	IN	B-PP	O
age	age	NN	B-NP	O
52	52	CD	I-NP	O
of	of	IN	B-PP	O
brain	brain	NN	B-NP	O
tumor	tumor	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
two	two	CD	B-NP	O
siblings	sibling	NNS	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
heart	heart	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

REVIEW	REVIEW	NNP	B-NP	O
OF	OF	IN	B-PP	O
SYSTEMS	SYSTEMS	NNP	B-NP	O
:	:	:	O	O
Otherwise	Otherwise	RB	B-NP	O
negative	negative	JJ	I-NP	O
other	other	JJ	B-ADJP	O
than	than	IN	B-SBAR	O
mentioned	mention	VBN	B-VP	O
in	in	IN	B-PP	O
HPI	HPI	NN	B-NP	B-cell_line
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Upon	Upon	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
temp	temp	NN	B-NP	O
97	97	CD	I-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
78	78	CD	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
16	16	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
144/52	144/52	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
pulse	pulse	NN	B-NP	O
oxymetry	oxymetry	NN	I-NP	O
99	99	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

General	General	NNP	B-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
pleasant	pleasant	JJ	I-NP	O
elderly	elderly	JJ	I-NP	O
female	female	NN	I-NP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
,	,	,	O	O
slightly	slightly	RB	B-VP	O
slurred	slur	VBD	I-VP	O
speech	speech	NN	B-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
,	,	,	O	O
normocephalic	normocephalic	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
atraumatic	atraumatic	JJ	I-ADJP	O
.	.	.	O	O

Extraocular	Extraocular	JJ	B-NP	O
motions	motion	NNS	I-NP	O
are	be	VBP	B-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Neck	Neck	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
supple	supple	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
thyroid	thyroid	JJ	I-NP	O
enlargement	enlargement	NN	I-NP	O
,	,	,	O	O
bilateral	bilateral	JJ	B-NP	O
carotid	carotid	NN	I-NP	O
bruits	bruit	NNS	I-NP	O
palpable	palpable	JJ	B-ADJP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-NP	O
,	,	,	I-NP	O
distant	distant	JJ	I-NP	O
heart	heart	NN	I-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
regular	regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
2/6	2/6	CD	I-NP	O
systolic	systolic	JJ	I-NP	O
ejection	ejection	NN	I-NP	O
murmur	murmur	NN	I-NP	O
heard	hear	VBN	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	B-protein
sternal	sternal	JJ	I-NP	I-protein
base	base	NN	I-NP	I-protein
.	.	.	O	O

No	No	DT	B-NP	O
rubs	rub	NNS	I-NP	O
or	or	CC	I-NP	O
gallops	gallop	NNS	I-NP	O
.	.	.	O	O

Crackles	Crackle	NNS	B-NP	O
heavily	heavily	RB	B-ADVP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
chest	chest	NN	I-NP	O
wall	wall	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
wheezes	wheeze	NNS	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
is	be	VBZ	B-VP	O
soft	soft	JJ	B-ADJP	O
,	,	,	O	O
nontender	nontender	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
nondistended	nondistended	JJ	B-ADJP	O
.	.	.	O	O

Bowel	Bowel	NN	B-NP	O
sounds	sound	NNS	I-NP	O
are	be	VBP	B-VP	O
present	present	JJ	B-ADJP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
clubbing	clubbing	NN	I-NP	O
or	or	CC	I-NP	O
cyanosis	cyanosis	NN	I-NP	O
.	.	.	O	O

Pedal	Pedal	JJ	B-NP	O
pulses	pulse	NNS	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
+	+	SYM	B-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
right	right	JJ	B-ADJP	O
.	.	.	O	O

Neuro	Neuro	RB	B-ADVP	O
,	,	,	O	O
cranial	cranial	JJ	B-NP	O
nerves	nerve	NNS	I-NP	O
II	II	CD	B-NP	O
through	through	IN	B-PP	O
XII	XII	CD	B-NP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Strength	Strength	NN	B-NP	O
5/5	5/5	CD	I-NP	O
diffusely	diffusely	RB	B-ADVP	O
,	,	,	O	O
light	light	JJ	B-NP	O
touch	touch	NN	I-NP	O
intact	intact	JJ	I-NP	O
throughout	throughout	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
dysmetria	dysmetria	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
difficulty	difficulty	NN	I-NP	O
with	with	IN	B-PP	O
alternating	alternate	VBG	B-NP	O
movements	movement	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
negative	negative	JJ	B-NP	O
pronator	pronator	NN	I-NP	O
drift	drift	NN	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Labs	Lab	NNS	B-NP	B-protein
upon	upon	IN	B-PP	O
admission	admission	NN	B-NP	O
included	include	VBN	B-VP	O
?	?	.	O	O
?	?	.	O	O
__	__	''	O	B-cell_line
?	?	.	O	O
?	?	.	O	O
creatinine	creatinine	NN	B-NP	O
of	of	IN	B-PP	O
3.1	3.1	CD	B-NP	O
,	,	,	O	O
otherwise	otherwise	RB	B-ADVP	O
the	the	DT	B-NP	O
electrolytes	electrolyte	NNS	I-NP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
,	,	,	O	O
sodium	sodium	NN	B-NP	O
129	129	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
glucose	glucose	NN	B-NP	B-protein
132	132	CD	I-NP	I-protein
.	.	.	O	O

LFTs	LFT	NNS	B-NP	O
were	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

Hemogram	Hemogram	NN	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
mildly	mildly	RB	I-NP	O
depressed	depressed	JJ	I-NP	O
hematocrit	hematocrit	NN	I-NP	O
of	of	IN	B-PP	O
32	32	CD	B-NP	O
,	,	,	O	O
troponin	troponin	NN	B-NP	O
elevated	elevate	VBD	B-VP	O
at	at	IN	B-PP	O
14.4	14.4	CD	B-NP	O
,	,	,	O	O
CK	CK	NN	B-NP	B-protein
364	364	CD	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
CKMB	CKMB	NN	B-NP	B-protein
28.3	28.3	CD	I-NP	I-protein
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
upon	upon	IN	B-PP	O
admission	admission	NN	B-NP	O
showed	show	VBD	B-VP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
at	at	IN	B-PP	O
83	83	CD	B-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
axis	axis	NN	I-NP	O
,	,	,	O	O
ST	ST	NN	B-NP	O
depressions	depression	NNS	I-NP	O
noted	note	VBN	B-VP	O
in	in	IN	B-PP	O
leads	lead	VBZ	B-VP	O
II	II	CD	B-NP	O
V5	V5	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
V6	V6	NN	B-NP	B-protein
.	.	.	O	O

No	No	DT	B-NP	O
ST	ST	NN	I-NP	O
elevations	elevation	NNS	I-NP	O
.	.	.	O	O

Q	Q	NN	B-NP	O
waves	wave	NNS	I-NP	O
in	in	IN	B-PP	O
III	III	CD	B-NP	O
and	and	CC	O	O
F.	F.	NNP	B-NP	O
T	T	NNP	I-NP	O
wave	wave	NN	I-NP	O
inversions	inversion	NNS	I-NP	O
noted	note	VBN	B-VP	O
in	in	IN	B-PP	O
I	I	PRP	B-NP	O
through	through	IN	B-PP	O
III	III	CD	B-NP	O
,	,	,	O	O
F	F	NN	B-NP	O
,	,	,	O	O
V6	V6	NN	B-NP	B-protein
,	,	,	O	O
poor	poor	JJ	B-NP	O
R-wave	R-wave	NN	I-NP	O
progression	progression	NN	I-NP	O
.	.	.	O	O

ASSESSMENT	ASSESSMENT	NN	B-NP	O
AND	AND	CC	I-NP	O
PLAN	PLAN	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
61-year-old	61-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
vasculopathies	vasculopathy	NNS	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
non-ST	non-ST	JJ	I-NP	O
elevation	elevation	NN	I-NP	O
MI	MI	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
markedly	markedly	RB	B-NP	O
elevated	elevated	JJ	I-NP	O
troponin	troponin	NN	I-NP	O
and	and	CC	O	O
progressive	progressive	JJ	B-NP	O
T-wave	T-wave	NN	I-NP	O
inversions	inversion	NNS	I-NP	O
laterally	laterally	RB	B-ADVP	O
.	.	.	O	O

1	1	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
,	,	,	O	O
following	follow	VBG	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
initiated	initiate	VBN	I-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
Plavix	Plavix	NN	B-NP	O
,	,	,	O	O
nitroglycerin	nitroglycerin	NN	B-NP	B-protein
drip	drip	NN	I-NP	I-protein
,	,	,	O	O
oxygen	oxygen	NN	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
beta-blocker	beta-blocker	NN	I-NP	O
was	be	VBD	B-VP	O
titrated	titrate	VBN	I-VP	O
up	up	RP	B-PRT	O
as	as	RB	O	O
tolerated	tolerate	VBN	B-VP	O
.	.	.	O	O

ACE	ACE	NN	B-NP	O
inhibitor	inhibitor	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
hydralazine	hydralazine	NN	B-NP	O
were	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
.	.	.	O	O

Over	Over	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
night	night	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
noted	note	VBD	B-VP	O
increasing	increase	VBG	I-VP	O
chest	chest	NN	B-NP	O
discomfort	discomfort	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
was	be	VBD	B-VP	O
titrated	titrate	VBN	I-VP	O
up	up	RP	B-PRT	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
showed	show	VBD	B-VP	O
continued	continue	VBN	B-NP	O
T	T	NN	I-NP	O
wave	wave	NN	I-NP	O
inversions	inversion	NNS	I-NP	O
laterally	laterally	RB	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
marked	marked	JJ	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
troponin	troponin	NN	B-NP	O
up	up	IN	B-PP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
elevation	elevation	NN	I-NP	O
of	of	IN	B-PP	O
105	105	CD	B-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	O
fellow	fellow	NN	I-NP	O
was	be	VBD	B-VP	O
contacted	contact	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
titrated	titrate	VBN	I-VP	O
up	up	RP	B-PRT	O
further	further	RBR	B-ADVP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
max	max	NN	I-NP	O
of	of	IN	B-PP	O
200	200	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
night	night	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
EKG	EKG	NN	B-NP	O
changes	change	NNS	I-NP	O
and	and	CC	O	O
elevated	elevated	JJ	B-NP	O
troponin	troponin	NN	I-NP	O
as	as	IN	B-SBAR	O
mentioned	mention	VBN	B-VP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
following	follow	VBG	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
11/8/05	11/8/05	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
new	new	JJ	B-NP	O
onset	onset	NN	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
discomfort	discomfort	NN	I-NP	O
and	and	CC	B-PP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
ST	ST	JJ	B-NP	O
elevations	elevation	NNS	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
inferior	inferior	NN	I-NP	O
leads	lead	VBZ	B-VP	O
III	III	CD	B-NP	O
and	and	CC	O	O
F	F	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
V6	V6	NN	B-NP	B-protein
and	and	CC	I-NP	O
L	L	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
continued	continued	JJ	I-NP	O
chest	chest	NN	I-NP	O
discomfort	discomfort	NN	I-NP	O
and	and	CC	O	O
new	new	JJ	B-NP	O
ST	ST	NN	I-NP	O
elevation	elevation	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
cath	cath	NN	I-NP	O
lab	lab	NN	I-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
which	which	WDT	B-NP	O
time	time	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
three-vessel	three-vessel	JJ	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
CABG	CABG	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
90	90	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
occlusion	occlusion	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
SVG	SVG	NN	I-NP	O
graft	graft	NN	I-NP	O
to	to	TO	B-PP	O
RTPDA	RTPDA	NN	B-NP	B-protein
status	status	NN	I-NP	I-protein
post	post	NN	I-NP	I-protein
PDA	PDA	NN	I-NP	I-protein
.	.	.	O	O

These	These	DT	B-NP	O
lesions	lesion	NNS	I-NP	O
were	be	VBD	B-VP	O
intervened	intervene	VBN	I-VP	O
upon	upon	IN	B-PP	O
with	with	IN	B-PP	O
drug	drug	NN	B-NP	B-protein
eluding	elude	VBG	B-VP	I-protein
stents	stent	NNS	B-NP	I-protein
x	x	SYM	B-NP	I-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

Following	Follow	VBG	B-PP	O
the	the	DT	B-NP	O
catheterization	catheterization	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
medical	medical	JJ	I-NP	O
management	management	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
remained	remain	VBD	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
free	free	JJ	B-ADJP	O
and	and	CC	O	O
the	the	DT	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
drip	drip	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

Following	Follow	VBG	B-PP	O
the	the	DT	B-NP	O
cath	cath	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
troponins	troponin	NNS	I-NP	O
trended	trend	VBD	B-VP	O
down	down	RB	B-ADVP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
mild	mild	JJ	B-NP	O
ST	ST	NN	I-NP	O
elevations	elevation	NNS	I-NP	O
that	that	WDT	B-NP	O
persisted	persist	VBD	B-VP	O
inferiorly	inferiorly	RB	B-ADVP	O
but	but	CC	O	O
were	be	VBD	B-VP	O
diminished	diminish	VBN	I-VP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
.	.	.	O	O

Preventive	Preventive	JJ	B-NP	O
measures	measure	NNS	I-NP	O
including	include	VBG	B-PP	O
nutrition	nutrition	NN	B-NP	O
and	and	CC	I-NP	O
smoking	smoking	NN	I-NP	O
sensation	sensation	NN	I-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
appears	appear	VBZ	B-VP	O
reluctant	reluctant	JJ	B-ADJP	O
to	to	TO	B-VP	O
quit	quit	VB	I-VP	O
smoking	smoking	NN	B-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-NP	O
pump	pump	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
well	well	RB	I-VP	O
controlled	control	VBN	I-VP	O
throughout	throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

Isordil	Isordil	NN	B-NP	O
and	and	CC	I-NP	O
hydralazine	hydralazine	NN	I-NP	O
were	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
held	hold	VBN	I-VP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
while	while	IN	B-SBAR	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	B-protein
drip	drip	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
ACE	ACE	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
acute	acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
beta-blocker	beta-blocker	NN	I-NP	O
was	be	VBD	B-VP	O
titrated	titrate	VBN	I-VP	O
up	up	RP	B-PRT	O
.	.	.	O	O

Upon	Upon	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
may	may	MD	B-VP	O
reinitiate	reinitiate	VB	I-VP	O
on	on	IN	B-PP	O
low-dose	low-dose	JJ	B-NP	O
hydralazine	hydralazine	NN	I-NP	O
and	and	CC	I-NP	O
Isordil	Isordil	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
reinitiation	reinitiation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ACE	ACE	NN	I-NP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-VP	O
with	with	IN	B-PP	O
renal	renal	JJ	B-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
diastolic	diastolic	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
likely	likely	RB	B-ADJP	O
due	due	JJ	I-ADJP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
from	from	IN	B-PP	O
October	October	NNP	B-NP	O
2005	2005	CD	I-NP	O
during	during	IN	B-PP	O
a	a	DT	B-NP	O
prior	prior	JJ	I-NP	O
admission	admission	NN	I-NP	O
for	for	IN	B-PP	O
heat	heat	NN	B-NP	O
failure	failure	NN	I-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	B-protein
of	of	IN	B-PP	O
60	60	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
inferior	inferior	JJ	B-NP	O
apical	apical	JJ	I-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
elevated	elevated	JJ	I-NP	O
LVEDP	LVEDP	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
appeared	appear	VBD	B-VP	O
mildly	mildly	RB	B-ADJP	O
hypervolemic	hypervolemic	JJ	I-ADJP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
but	but	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
show	show	VB	I-VP	O
any	any	DT	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

Initially	Initially	RB	B-NP	O
diuresis	diuresis	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
acute	acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
received	receive	VBD	B-VP	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
x1	x1	NN	I-NP	O
on	on	IN	B-PP	O
2/16/05	2/16/05	CD	B-NP	O
due	due	JJ	B-ADVP	O
to	to	TO	B-PP	O
abdominal	abdominal	JJ	B-NP	O
discomfort	discomfort	NN	I-NP	O
and	and	CC	I-NP	O
distention	distention	NN	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
mild	mild	JJ	B-NP	O
volume	volume	NN	I-NP	O
overload	overload	NN	I-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
throughout	throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
arrhythmias	arrhythmia	NNS	B-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
events	event	NNS	I-NP	O
were	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
telemetry	telemetry	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
obtained	obtain	VBD	B-VP	O
EKGs	EKG	NNS	B-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
change	change	NN	I-NP	O
or	or	CC	I-NP	O
nodal	nodal	JJ	I-NP	O
blockage	blockage	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Endocrine	Endocrine	JJ	B-ADJP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
insulin-dependent	insulin-dependent	JJ	B-NP	O
diabetes	diabete	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
moderately	moderately	RB	I-VP	O
well	well	RB	I-VP	O
controlled	control	VBN	I-VP	O
throughout	throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hemoglobin	hemoglobin	NN	B-NP	B-protein
A1c	A1c	NN	I-NP	O
of	of	IN	B-PP	O
7.3	7.3	CD	B-NP	O
as	as	IN	B-PP	O
of	of	IN	B-PP	O
February	February	NNP	B-NP	O
2005	2005	CD	I-NP	O
.	.	.	O	O

Upon	Upon	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
glyburide	glyburide	NN	B-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
Lantus	Lantus	NNP	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
of	of	IN	B-PP	O
Regular	Regular	JJ	B-NP	B-protein
Insulin	Insulin	NN	I-NP	I-protein
.	.	.	O	O

She	She	PRP	B-NP	O
obtained	obtain	VBD	B-VP	O
fingers	finger	NNS	B-NP	O
sticks	stick	NNS	I-NP	O
a.c.	a.c.	NN	I-NP	O
and	and	CC	I-NP	O
h.s.	h.s.	NN	I-NP	O
Glipizide	Glipizide	NN	I-NP	O
was	be	VBD	B-VP	O
initiated	initiate	VBN	I-VP	O
on	on	IN	B-PP	O
2/16/05	2/16/05	CD	B-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
titrated	titrate	VBN	I-VP	O
up	up	RP	B-PRT	O
as	as	RB	B-VP	O
tolerated	tolerate	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Respiratory	Respiratory	NNP	B-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
system	system	NN	I-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
crackles	crackle	NNS	B-NP	O
on	on	IN	B-PP	O
exam	exam	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
edema	edema	NN	I-NP	O
on	on	IN	B-PP	O
chest	chest	NN	B-NP	O
x-ray	x-ray	NN	I-NP	O
.	.	.	O	O

Abdominal	Abdominal	JJ	B-NP	O
CT	CT	NN	I-NP	O
on	on	IN	B-PP	O
7/16/05	7/16/05	CD	B-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
moderate	moderate	JJ	B-NP	O
right	right	NN	I-NP	O
and	and	CC	I-NP	O
trace	trace	NN	I-NP	O
left	leave	VBD	B-VP	O
pleural	pleural	JJ	B-NP	O
effusions	effusion	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
maintained	maintain	VBD	B-VP	O
excellent	excellent	JJ	B-NP	O
pulse	pulse	NN	I-NP	O
oximetry	oximetry	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
respiratory	respiratory	JJ	I-NP	O
compromise	compromise	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADVP	O
,	,	,	O	O
upon	upon	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
acute	acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
3.2	3.2	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
hypertensive	hypertensive	JJ	B-NP	O
nephropathy	nephropathy	NN	I-NP	O
,	,	,	O	O
diabetic	diabetic	JJ	B-NP	O
nephropathy	nephropathy	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
likely	likely	JJ	B-NP	O
renal	renal	JJ	I-NP	O
artery	artery	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
.	.	.	O	O

Prior	Prior	JJ	B-NP	O
renal	renal	JJ	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
atrophic	atrophic	JJ	I-NP	O
left	left	JJ	I-NP	O
kidney	kidney	NN	I-NP	O
with	with	IN	B-PP	O
mild	mild	JJ	B-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
perfusion	perfusion	NN	B-NP	O
.	.	.	O	O

Following	Follow	VBG	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
initiated	initiate	VBN	I-VP	O
on	on	IN	B-PP	O
D5W	D5W	NN	B-NP	B-protein
with	with	IN	B-PP	O
3	3	CD	B-NP	O
ampules	ampule	NNS	I-NP	O
of	of	IN	B-PP	O
bicarb	bicarb	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
Mucomyst	Mucomyst	NN	B-NP	O
in	in	IN	B-PP	O
preparation	preparation	NN	B-NP	O
for	for	IN	B-PP	O
likely	likely	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
IV	IV	CD	B-NP	O
fluids	fluid	NNS	I-NP	O
following	follow	VBG	B-PP	O
the	the	DT	B-NP	O
catheterization	catheterization	NN	I-NP	O
.	.	.	O	O

Despite	Despite	IN	B-PP	O
these	these	DT	B-NP	O
preventive	preventive	JJ	I-NP	O
measures	measure	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
marked	marked	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
following	follow	VBG	B-PP	O
cardiac	cardiac	JJ	B-NP	O
cath	cath	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
high	high	JJ	I-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
5	5	CD	B-NP	O
on	on	IN	B-PP	O
7/20/05	7/20/05	CD	B-NP	O
.	.	.	O	O

Renal	Renal	JJ	B-NP	O
consult	consult	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
and	and	CC	O	O
advised	advise	VBN	B-VP	O
continued	continued	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
urine	urine	NN	I-NP	O
sediment	sediment	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
ATN	ATN	NN	B-NP	B-protein
.	.	.	O	O

An	An	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
CT	CT	NN	I-NP	O
showed	show	VBD	B-VP	O
evidence	evidence	NN	B-NP	O
again	again	RB	B-ADVP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
atrophic	atrophic	JJ	I-NP	O
left	left	JJ	I-NP	O
kidney	kidney	NN	I-NP	O
.	.	.	O	O

Creatinine	Creatinine	NN	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
begin	begin	VB	I-VP	O
to	to	TO	I-VP	O
decrease	decrease	VB	I-VP	O
on	on	IN	B-PP	O
7/16/05	7/16/05	CD	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
4.2	4.2	CD	B-NP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
before	before	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Lamantia	Lamantia	NNP	I-NP	O
in	in	IN	B-PP	O
Nephrology	Nephrology	NNP	B-NP	O
within	within	IN	B-PP	O
three	three	CD	B-NP	O
months	month	NNS	I-NP	O
'	'	POS	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

GI	GI	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
right	right	JJ	B-NP	B-protein
upper	upper	JJ	I-NP	I-protein
quadrant	quadrant	JJ	I-NP	I-protein
abdominal	abdominal	JJ	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
on	on	IN	B-PP	O
7/20/05	7/20/05	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
had	have	VBN	I-VP	O
mild	mild	JJ	B-NP	O
elevations	elevation	NNS	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
LFTs	LFT	NNS	I-NP	B-protein
,	,	,	O	O
most	most	RBS	B-ADVP	O
notably	notably	RB	I-ADVP	O
an	an	DT	B-NP	O
alk	alk	NN	I-NP	O
phos	pho	NNS	I-NP	O
of	of	IN	B-PP	O
293	293	CD	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
these	these	DT	B-NP	O
values	value	NNS	I-NP	O
stabilized	stabilize	VBD	B-VP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
remainder	remainder	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
CT	CT	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
without	without	IN	B-PP	O
contrast	contrast	NN	B-NP	O
that	that	WDT	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
sign	sign	NN	I-NP	O
of	of	IN	B-PP	O
obstruction	obstruction	NN	B-NP	O
,	,	,	O	O
hepatobiliary	hepatobiliary	JJ	B-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
ventral	ventral	JJ	I-NP	O
hernia	hernia	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
strangulated	strangulate	VBN	I-VP	O
or	or	CC	I-VP	O
incarcerated	incarcerate	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
pass	pass	VB	I-VP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
regular	regular	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
movements	movement	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
bowel	bowel	NN	B-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
pain	pain	NN	I-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
likely	likely	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
ventral	ventral	JJ	B-NP	O
hernia	hernia	NN	I-NP	O
with	with	IN	B-PP	O
increased	increase	VBN	B-NP	O
volume	volume	NN	I-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
a	a	DT	B-NP	O
mild	mild	JJ	I-NP	O
diuresis	diuresis	NN	I-NP	O
to	to	TO	B-VP	O
decrease	decrease	VB	I-VP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

ID	ID	NN	B-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Heme	Heme	NNP	B-NP	B-protein
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
drop	drop	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
cath	cath	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
dropped	drop	VBD	B-VP	O
from	from	IN	B-PP	O
32	32	CD	B-NP	O
to	to	TO	B-PP	O
26	26	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
transfused	transfuse	VBN	I-VP	O
two	two	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
packed	packed	JJ	B-NP	B-cell_type
red	red	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
catheterization	catheterization	NN	B-NP	O
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
keep	keep	VB	I-VP	O
the	the	DT	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
30	30	CD	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
blood	blood	NN	B-NP	O
loss	loss	NN	I-NP	O
noted	note	VBD	B-VP	O
.	.	.	O	O

Guaiac	Guaiac	JJ	B-NP	O
stools	stool	NNS	I-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
likely	likely	RB	B-ADJP	O
a	a	DT	B-NP	O
component	component	NN	I-NP	O
of	of	IN	B-PP	O
anemia	anemia	NN	B-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
disease	disease	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
trend	trend	VB	I-VP	O
down	down	IN	B-PP	O
and	and	CC	I-PP	O
on	on	IN	I-PP	O
7/16/05	7/16/05	CD	B-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
CT	CT	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
to	to	TO	I-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
retroperitoneal	retroperitoneal	JJ	B-NP	O
bleed	bleed	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
transfused	transfuse	VBN	I-VP	O
one	one	CD	B-NP	O
unit	unit	NN	I-NP	O
of	of	IN	B-PP	O
packed	packed	JJ	B-NP	B-cell_type
red	red	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
on	on	IN	B-PP	O
7/16/05	7/16/05	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
likely	likely	RB	I-VP	O
require	require	VB	I-VP	O
a	a	DT	B-NP	O
further	further	JJ	I-NP	O
anemia	anemia	NN	I-NP	O
workup	workup	NN	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

FEN	FEN	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
given	give	VBN	I-VP	O
any	any	DT	B-NP	O
electrolyte	electrolyte	NN	I-NP	O
scales	scale	NNS	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
acute	acute	JJ	I-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
hyponatremia	hyponatremia	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
lowest	low	JJS	I-NP	O
of	of	IN	B-PP	O
123	123	CD	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
therefore	therefore	RB	I-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
free	free	JJ	B-NP	O
water	water	NN	I-NP	O
1.5-liter	1.5-liter	NN	I-NP	O
restriction	restriction	NN	I-NP	O
with	with	IN	B-PP	O
adequate	adequate	JJ	B-NP	O
resolution	resolution	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
less	less	JJR	I-NP	O
than	than	IN	B-PP	O
2-gm	2-gm	JJ	B-NP	O
salt	salt	NN	I-NP	O
restriction	restriction	NN	I-NP	O
to	to	TO	B-VP	O
decrease	decrease	VB	I-VP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
increased	increase	VBN	I-NP	O
phosphorous	phosphorous	JJ	I-NP	O
level	level	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
PhosLo	PhosLo	NNP	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
potassiums	potassium	NNS	B-NP	O
,	,	,	O	O
but	but	CC	O	O
this	this	DT	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
exceed	exceed	VB	I-VP	O
5	5	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
cardiac/renal	cardiac/renal	JJ	I-NP	O
1800	1800	CD	I-NP	O
ADA	ADA	NN	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

Prophylaxis	Prophylaxis	NN	B-NP	O
included	include	VBD	B-VP	O
SCD	SCD	NN	B-NP	O
and	and	CC	I-NP	O
Pneumoboots	Pneumoboot	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
anemia	anemia	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
proton	proton	NN	I-NP	O
pump	pump	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
.	.	.	O	O

CODE	CODE	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
DNR/DNI	DNR/DNI	NNP	B-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
Upon	Upon	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
home	home	NN	B-ADVP	O
without	without	IN	B-PP	O
service	service	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
ambulate	ambulate	VB	I-VP	O
without	without	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
or	or	CC	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
tolerating	tolerate	VBG	B-VP	O
p.o.	p.o.	FW	B-NP	O
intake	intake	FW	I-NP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
have	have	VB	I-VP	O
follow-up	follow-up	NN	B-NP	O
as	as	IN	B-SBAR	O
noted	note	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
addendum	addendum	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
instructed	instruct	VBN	I-VP	O
not	not	RB	O	O
to	to	TO	B-VP	O
smoke	smoke	VB	I-VP	O
and	and	CC	O	O
to	to	TO	B-VP	O
take	take	VB	I-VP	O
daily	daily	JJ	B-NP	O
weights	weight	NNS	I-NP	O
and	and	CC	O	O
if	if	IN	B-SBAR	O
she	she	PRP	B-NP	O
gained	gain	VBD	B-VP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
2	2	CD	I-NP	O
pounds	pound	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
or	or	CC	O	O
5	5	CD	B-NP	O
pounds	pound	NNS	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
instructed	instruct	VBN	I-VP	O
to	to	TO	I-VP	O
call	call	VB	I-VP	O
her	her	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
should	should	MD	B-VP	O
seek	seek	VB	I-VP	O
medical	medical	JJ	B-NP	O
attention	attention	NN	I-NP	O
for	for	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
weight	weight	NN	B-NP	O
gain	gain	NN	I-NP	O
,	,	,	O	O
dizziness	dizziness	NN	B-NP	O
,	,	,	O	O
worsening	worsen	VBG	B-VP	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
any	any	DT	B-NP	O
other	other	JJ	I-NP	O
concerns	concern	NNS	I-NP	O
.	.	.	O	O

PLAN	PLAN	NN	B-NP	B-protein
:	:	:	O	I-protein
1	1	LS	B-LST	I-protein
.	.	.	O	O

Follow	Follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Chesebro	Chesebro	NNP	I-NP	O
,	,	,	O	O
monitor	monitor	NN	B-NP	O
for	for	IN	B-PP	O
continued	continued	JJ	B-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
creatinine	creatinine	NN	B-NP	O
.	.	.	O	O

Consider	Consider	VB	B-VP	O
reinitiating	reinitiate	VBG	I-VP	O
the	the	DT	B-NP	O
ACE	ACE	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
with	with	IN	B-PP	O
resolution	resolution	NN	B-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

Titrate	Titrate	VB	B-VP	O
the	the	DT	B-NP	O
beta-blocker	beta-blocker	NN	I-NP	O
and	and	CC	O	O
restart	restart	VB	B-VP	O
nitrates	nitrate	NNS	B-NP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-VP	O
.	.	.	O	O

Titrate	Titrate	VB	B-VP	O
up	up	RP	B-PRT	O
glipizide	glipizide	NN	B-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

Consider	Consider	VB	B-VP	O
further	further	JJ	B-NP	O
anemia	anemia	NN	I-NP	O
workup	workup	NN	I-NP	O
.	.	.	O	O

Encourage	Encourage	NN	B-NP	O
smoking	smoking	NN	I-NP	O
sensation	sensation	NN	I-NP	O
.	.	.	O	O

Continue	Continue	NNP	B-NP	O
to	to	TO	B-VP	O
monitor	monitor	VB	I-VP	O
abdominal	abdominal	JJ	B-NP	O
pain/LFTs	pain/LFT	NNS	I-NP	O
and	and	CC	O	O
consider	consider	VB	B-VP	O
further	further	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
of	of	IN	B-PP	O
ventral	ventral	JJ	B-NP	O
hernia	hernia	NN	I-NP	O
.	.	.	O	O

Check	Check	NN	B-NP	O
LFTs	LFT	NNS	I-NP	O
with	with	IN	B-PP	O
recent	recent	JJ	B-NP	O
addition	addition	NN	I-NP	O
of	of	IN	B-PP	O
Lipitor	Lipitor	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Follow	Follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Burkle	Burkle	NNP	I-NP	O
post	post	IN	B-PP	O
MI	MI	NNP	B-NP	O
management	management	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Follow	Follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Bottrell	Bottrell	NNP	I-NP	O
for	for	IN	B-PP	O
management	management	NN	B-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
3-4867035	3-4867035	CD	B-NP	O
CSSten	CSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
MERANTO	MERANTO	NNP	B-NP	O
,	,	,	O	O
JOHNIE	JOHNIE	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
RICOTTA	RICOTTA	NNP	B-NP	O
,	,	,	O	O
JOHNATHAN	JOHNATHAN	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
9210960	9210960	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
2/16/05	2/16/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
2/16/05	2/16/05	CD	B-NP	O

